Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-132-1 | CAS number: 52722-86-8
Endpoint summary
Administrative data
Description of key information
- Oral: LD50 rat > 2000mg/kg (limit test, OECD 401)
- Dermal: LD50 rat > 2000 mg/kg (limit test, OECD 402)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute oral toxicity
In a GLP-compliant acute oral toxicity study following OECD guideline 401, the test substance in 0.5 % (w/v) carboxymethylcellulose in 0.1 % (w/v) aqueous polysorbate 80 was administered by oral gavage to five Tif: RAI f (SPF) rats of each sex at 2000 mg/kg body weight. Animals were subjected to daily observations and weekly determination of body weight for a period of 14 days. Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. All animals had recovered from the symptoms within six days. The body weight gain shown by the animals over the study period was considered to be normal. No abnormalities were found at macroscopic post mortem examination of the animals. Therefore, the oral LD value in rats was established to exceed 2000 mg/kg body weight (Ciba-Geigy, 1992).
Dermal
In a GLP-compliant acute dermal toxicity study the test article in distilled water was administered to five Tif: RAI f (SPF) rats of each sex by dermal application at 2000 mg/kg body weight for 24 hours. Animals were subjected to daily observations and weekly determination of body weight. No mortality occurred. Piloerection was seen, being a common symptom in acute dermal tests. The animals recovered within 1 day. The mean body weight gain during the observation period was within the range expected for rats used in this type of study. No abnormalities were found at macroscopic post mortem examination of the animals. In conclusion, the dermal LD50 value in rats was established to exceed 2000 mg/kg body weight (Ciba-Geigy, 1992).
Justification for selection of acute toxicity – oral endpoint
GLP-compliant guideline study
Justification for selection of acute toxicity – dermal endpoint
GLP-compliant guideline study
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008 (CLP). As a result the substance is not considered to be classified for acute toxicity under Regulation (EC) No 1272/2008, as amended for the sixth time in Regulation (EC) No 605/2014.
Dangerous Substance Directive (67/548/EEC)
The available study are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for acute toxicity under Directive 67/548/EEC, as amended for the 31st time in Directive 2009/2/EG.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
